HBsAg-vectored vaccines simultaneously deliver CTL responses to protective epitopes from multiple viral pathogens

Virology

Volumn 398, Issue 1, 2010, Pages 68-78

  Chen, Dekun ^a,b   Edgtton, Kristy ^a   Gould, Allan ^a   Guo, Huayang ^a   Mather, Michael ^a   Haigh, Oscar ^a   Cochrane, Melanie ^a   Kattenbelt, Jacqueline ^a   Thomson, Scott ^a   Tindle, Robert ^a  

^a ROYAL CHILDREN'S HOSPITAL   (Australia)

^b NORTHWEST A F UNIVERSITY   (China)

Author keywords

Cytotoxic T lymphocyte; Hepatitis B surface antigen; Polyepitope; Recombinant DNA vaccine; Vaccine vector

Indexed keywords

DNA VACCINE; HEPATITIS B SURFACE ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MULTIEPITOPE 2; POLYEPITOPE 3; RECOMBINANT DNA; UNCLASSIFIED DRUG; VIRUS VECTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIVIRAL ACTIVITY; ARTICLE; CARBOXY TERMINAL SEQUENCE; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; FEMALE; HAPLOTYPE; IMMUNIZATION; IMMUNOGENICITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; TUMOR IMMUNITY; VIRUS VIRULENCE;

ANIMALS; ANTIGENS, VIRAL, TUMOR; DNA, RECOMBINANT; DNA, VIRAL; EYE INFECTIONS, VIRAL; FEMALE; HEPATITIS B SURFACE ANTIGENS; MICE; MICE, INBRED BALB C; MICE, TRANSGENIC; SPLEEN; T-LYMPHOCYTES, CYTOTOXIC; VACCINES, SYNTHETIC; VIRAL VACCINES;

EID: 75849159736     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2009.11.042     Document Type: Article

References (48)

1. Alexander-Miller M.A., Leggatt G.R., and Berzofsky J.A. Selective expansion of high- or low-avidity cytotoxic T lymphocytes and efficacy for adoptive immunotherapy. Proc. Natl. Acad. Sci. U. S. A. 93 (1996) 4102-4107
2. Anderson K., Cresswell P., Gammon M., Hermes J., Williamson A., and Zweerink H. Endogenously synthesized peptide with an endoplasmic reticulum signal sequence sensitizes antigen processing mutant cells to class I-restricted cell-mediated lysis. J. Exp. Med. 174 2 (1991) 489-492 Aug 1
3. Ando K., Moriyama T., Guidotti L.G., Wirth S., Schreiber R.D., Schlicht H.J., Huang S.N., and Chisari F.V. Mechanisms of class I restricted immunopathology. A transgenic mouse model of fulminant hepatitis. J. Exp. Med. 178 (1993) 1541-1554
4. Bellone M., Cantarella D., Castiglioni P., Crosti M.C., Ronchetti A., Moro M., Garancini M.P., Casorati G., and Dellabona P. Relevance of the tumor antigen in the validation of three vaccination strategies for melanoma. J. Immunol. 165 (2000) 2651-2656
5. Berkower I., Raymond M., Muller J., Spadaccini A., and Aberdeen A. Assembly, structure, and antigenic properties of virus-like particles rich in HIV-1 envelope gp120. Virology 321 (2004) 75-86
6. Bisht H., Chugh D.A., Raje M., Swaminathan S.S., and Khanna N. Recombinant dengue virus type 2 envelope/hepatitis B surface antigen hybrid protein expressed in Pichia pastoris can function as a bivalent immunogen. J. Biotechnol. 99 (2002) 97-110
7. Bruss V., and Ganem D. Mutational analysis of hepatitis B surface antigen particle assembly and secretion. J. Virol. 65 (1991) 3813-3820
8. Bryder K., Sbai H., Nielsen H.V., Corbet S., Nielsen C., Whalen R.G., and Fomsgaard A. Improved immunogenicity of HIV-1 epitopes in HBsAg chimeric DNA vaccine plasmids by structural mutations of HBsAg. DNA Cell Biol. 18 (1999) 219-225
9. Callan M.F., Reyburn H.T., Bowness P., Rowland-Jones S., Bell J.I., and McMichael A.J. Selection of T cell receptor variable gene-encoded amino acids on the third binding site loop: a factor influencing variable chain selection in a T cell response. Eur. J. Immunol. 25 (1995) 1529-1534
10. Cannon M.J., Openshaw P.J., and Askonas B.A. Cytotoxic T cells clear virus but augment lung pathology in mice infected with respiratory syncytial virus. J. Exp. Med. 168 (1988) 1163-1168
11. Chargelegue D., Obeid O.E., Hsu S.C., Shaw M.D., Denbury A.N., Taylor G., and Steward M.W. A peptide mimic of a protective epitope of respiratory syncytial virus selected from a combinatorial library induces virus-neutralizing antibodies and reduces viral load in vivo. J. Virol. 72 (1998) 2040-2046
12. Chua P.K., Wang R.Y., Lin M.H., Masuda T., Suk F.M., and Shih C. Reduced secretion of virions and hepatitis B virus (HBV) surface antigen of a naturally occurring HBV variant correlates with the accumulation of the small S envelope protein in the endoplasmic reticulum and Golgi apparatus. J. Virol. 79 (2005) 13483-13496
13. Cid-Arregui A., Juarez V., and Zur H.H. A synthetic E7 gene of human papillomavirus type 16 that yields enhanced expression of the protein in mammalian cells and is useful for DNA immunization studies. J. Virol. 77 (2003) 4928-4937
14. Davis H.L., Mancini M., Michel M.L., and Whalen R.G. DNA-mediated immunization to hepatitis B surface antigen: longevity of primary response and effect of boost. Vaccine 14 (1996) 910-915
15. Davis H.L., Schirmbeck R., Reimann J., and Whalen R.G. DNA-mediated immunization in mice induces a potent MHC class I-restricted cytotoxic T lymphocyte response to the hepatitis B envelope protein. Hum. Gene Ther. 6 (1995) 1447-1456
16. Doan T., Chambers M., Street M., Fernando G.J., Herd K., Lambert P., and Tindle R. Mice expressing the E7 oncogene of HPV16 in epithelium show central tolerance, and evidence of peripheral anergising tolerance, to E7-encoded cytotoxic T-lymphocyte epitopes. Virology 244 (1998) 352-364
17. Feltkamp M.C., Smits H.L., Vierboom M.P., Minnaar R.P., de Jongh B.M., Drijfhout J.W., ter Schegget J., Melief C.J., and Kast W.M. Vaccination with cytotoxic T lymphocyte epitope-containing peptide protects against a tumor induced by human papillomavirus type 16-transformed cells. Eur. J. Immunol. 23 (1993) 2242-2249
18. Graham B.S., Perkins M.D., Wright P.F., and Karzon D.T. Primary respiratory syncytial virus infection in mice. J. Med. Virol. 26 (1988) 153-162
19. Gray D., Kosco M., and Stockinger B. Novel pathways of antigen presentation for the maintenance of memory. Int. Immunol. 3 (1991) 141-148
20. Gupta R.K., and Siber G.R. Adjuvants for human vaccines-current status, problems and future prospects. Vaccine 13 (1995) 1263-1276
21. Haigh O., Guo H., Edgtton K., Mather M., Herd K.A., and Tindle R.W. Multiple copies of a tumor epitope in a recombinant hepatitis B surface antigen (HBsAg) vaccine enhance CTL responses, but not tumor protection. Virology 368 (2007) 363-375
22. Herd K.A., Mahalingam S., Mackay I.M., Nissen M., Sloots T.P., and Tindle R.W. Cytotoxic T-lymphocyte epitope vaccination protects against human metapneumovirus infection and disease in mice. J. Virol. 80 (2006) 2034-2044
23. Hislop A.D., Taylor G.S., Sauce D., and Rickinson A.B. Cellular responses to viral infection in humans: lessons from Epstein-Barr virus. Annu. Rev. Immunol. 25 (2007) 587-617
24. Hsu S.C., Chargelegue D., and Steward M.W. Reduction of respiratory syncytial virus titer in the lungs of mice after intranasal immunization with a chimeric peptide consisting of a single CTL epitope linked to a fusion peptide. Virology 240 (1998) 376-381
25. Ishioka G.Y., Fikes J., Hermanson G., Livingston B., Crimi C., Qin M., del Guercio M.F., Oseroff C., Dahlberg C., Alexander J., Chesnut R.W., and Sette A. Utilization of MHC class I transgenic mice for development of minigene DNA vaccines encoding multiple HLA-restricted CTL epitopes. J. Immunol. 162 (1999) 3915-3925
26. Jiang S., Borthwick N.J., Morrison P., Gao G.F., and Steward M.W. Virus-specific CTL responses induced by an H-2K(d)-restricted, motif-negative 15-mer peptide from the fusion protein of respiratory syncytial virus. J. Gen. Virol. 83 (2002) 429-438
27. Kirman J.R., and Seder R.A. DNA vaccination: the answer to stable, protective T-cell memory?. Curr. Opin. Immunol. 15 (2003) 471-476
28. Le T.T., Drane D., Malliaros J., Cox J.C., Rothel L., Pearse M., Woodberry T., Gardner J., and Suhrbier A. Cytotoxic T cell polyepitope vaccines delivered by ISCOMs. Vaccine 19 (2001) 4669-4675
29. Leclerc C., Deriaud E., Rojas M., and Whalen R.G. The preferential induction of a Th1 immune response by DNA-based immunization is mediated by the immunostimulatory effect of plasmid DNA. Cell Immunol. 179 (1997) 97-106
30. Lin K.Y., Guarnieri F.G., Staveley-O'Carroll K.F., Levitsky H.I., August J.T., Pardoll D.M., and Wu T.C. Treatment of established tumors with a novel vaccine that enhances major histocompatibility class II presentation of tumor antigen. Cancer Res. 56 (1996) 21-26
31. Livingston B.D., Newman M., Crimi C., McKinney D., Chesnut R., and Sette A. Optimization of epitope processing enhances immunogenicity of multiepitope DNA vaccines. Vaccine 19 (2001) 4652-4660
32. Loirat D., Lemonnier F.A., and Michel M.L. Multiepitopic HLA-A*0201-restricted immune response against hepatitis B surface antigen after DNA-based immunization. J. Immunol. 165 (2000) 4748-4755
33. Michel M., Lone Y.C., Centlivre M., Roux P., Wain-Hobson S., and Sala M. Optimisation of secretion of recombinant HBsAg virus-like particles: impact on the development of HIV-1/HBV bivalent vaccines. Vaccine 25 (2007) 1901-1911
34. Netter H.J., Macnaughton T.B., Woo W.P., Tindle R., and Gowans E.J. Antigenicity and immunogenicity of novel chimeric hepatitis B surface antigen particles with exposed hepatitis C virus epitopes. J. Virol. 75 (2001) 2130-2141
35. Ressing M.E., de Jong J.H., Brandt R.M., Drijfhout J.W., Benckhuijsen W.E., Schreuder G.M., Offringa R., Kast W.M., and Melief C.J. Differential binding of viral peptides to HLA-A2 alleles. Implications for human papillomavirus type 16 E7 peptide-based vaccination against cervical carcinoma. Eur. J. Immunol. 29 (1999) 1292-1303
36. Rice J., Ottensmeier C.H., and Stevenson F.K. DNA vaccines: precision tools for activating effective immunity against cancer. Nat. Rev. Cancer 8 (2008) 108-120
37. Roberts L.K., Barr L.J., Fuller D.H., McMahon C.W., Leese P.T., and Jones S. Clinical safety and efficacy of a powdered Hepatitis B nucleic acid vaccine delivered to the epidermis by a commercial prototype device. Vaccine 23 (2005) 4867-4878
38. Rosenberg S.A. Progress in human tumor immunology and immunotherapy. Nature 411 (2001) 380-384
39. Roy M.J., Wu M.S., Barr L.J., Fuller J.T., Tussey L.G., Speller S., Culp J., Burkholder J.K., Swain W.F., Dixon R.M., Widera G., Vessey R., King A., Ogg G., Gallimore A., Haynes J.R., and Heydenburg F.D. Induction of antigen-specific CD8+ T cells, T helper cells, and protective levels of antibody in humans by particle-mediated administration of a hepatitis B virus DNA vaccine. Vaccine 19 (2000) 764-778
40. Sbai H., Schneider J., Hill A.V., and Whalen R.G. Role of transfection in the priming of cytotoxic T-cells by DNA-mediated immunization. Vaccine 20 (2002) 3137-3147
41. Schirmbeck R., Bohm W., Ando K., Chisari F.V., and Reimann J. Nucleic acid vaccination primes hepatitis B virus surface antigen-specific cytotoxic T lymphocytes in nonresponder mice. J. Virol. 69 (1995) 5929-5934
42. Schirmbeck R., Melber K., Kuhrober A., Janowicz Z.A., and Reimann J. Immunization with soluble hepatitis B virus surface protein elicits murine H-2 class I-restricted CD8+ cytotoxic T lymphocyte responses in vivo. J. Immunol. 152 (1994) 1110-1119
43. Sidney J., Peters B., Frahm N., Brander C., and Sette A. HLA class I supertypes: a revised and updated classification. BMC Immunol. 9 (2008) 1
44. Thomson S.A., Elliott S.L., Sherritt M.A., Sproat K.W., Coupar B.E., Scalzo A.A., Forbes C.A., Ladhams A.M., Mo X.Y., Tripp R.A., Doherty P.C., Moss D.J., and Suhrbier A. Recombinant polyepitope vaccines for the delivery of multiple CD8 cytotoxic T cell epitopes. J. Immunol. 157 (1996) 822-826
45. Thomson S.A., Sherritt M.A., Medveczky J., Elliott S.L., Moss D.J., Fernando G.J., Brown L.E., and Suhrbier A. Delivery of multiple CD8 cytotoxic T cell epitopes by DNA vaccination. J. Immunol. 160 (1998) 1717-1723
46. Valenzuela P., Gray P., Quiroga M., Zaldivar J., Goodman H.M., and Rutter W.J. Nucleotide sequence of the gene coding for the major protein of hepatitis B virus surface antigen. Nature 280 (1979) 815-819
47. Vitiello A., Marchesini D., Furze J., Sherman L.A., and Chesnut R.W. Analysis of the HLA-restricted influenza-specific cytotoxic T lymphocyte response in transgenic mice carrying a chimeric human-mouse class I major histocompatibility complex. J. Exp. Med. 173 (1991) 1007-1015
48. Woo W.P., Doan T., Herd K.A., Netter H.J., and Tindle R.W. Hepatitis B surface antigen vector delivers protective cytotoxic T-lymphocyte responses to disease-relevant foreign epitopes. J. Virol. 80 (2006) 3975-3984